Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 26% ± 11% | |
endothelial cell | 8 studies | 23% ± 6% | |
microglial cell | 7 studies | 24% ± 7% | |
epithelial cell | 7 studies | 37% ± 14% | |
astrocyte | 7 studies | 32% ± 12% | |
macrophage | 7 studies | 27% ± 5% | |
myeloid cell | 5 studies | 23% ± 8% | |
dendritic cell | 5 studies | 25% ± 10% | |
fibroblast | 5 studies | 19% ± 5% | |
type I pneumocyte | 5 studies | 21% ± 3% | |
oligodendrocyte precursor cell | 5 studies | 32% ± 12% | |
basal cell | 5 studies | 32% ± 17% | |
B cell | 4 studies | 18% ± 2% | |
hematopoietic precursor cell | 4 studies | 24% ± 8% | |
retinal pigment epithelial cell | 4 studies | 37% ± 15% | |
cardiac muscle cell | 4 studies | 18% ± 2% | |
ciliated cell | 4 studies | 26% ± 8% | |
type II pneumocyte | 4 studies | 22% ± 5% | |
GABAergic neuron | 4 studies | 41% ± 11% | |
glutamatergic neuron | 4 studies | 45% ± 9% | |
monocyte | 4 studies | 21% ± 2% | |
classical monocyte | 3 studies | 22% ± 5% | |
conventional dendritic cell | 3 studies | 27% ± 10% | |
lymphocyte | 3 studies | 21% ± 2% | |
abnormal cell | 3 studies | 22% ± 7% | |
granulocyte monocyte progenitor cell | 3 studies | 20% ± 3% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 7% | |
intestinal crypt stem cell | 3 studies | 19% ± 3% | |
alveolar macrophage | 3 studies | 21% ± 6% | |
transit amplifying cell | 3 studies | 33% ± 21% | |
interneuron | 3 studies | 44% ± 18% | |
neuron | 3 studies | 33% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1248.72 | 459 / 459 | 100% | 26.66 | 1118 / 1118 |
esophagus | 100% | 1268.03 | 1445 / 1445 | 100% | 26.50 | 183 / 183 |
stomach | 100% | 1047.39 | 359 / 359 | 100% | 35.89 | 286 / 286 |
uterus | 100% | 1310.22 | 170 / 170 | 100% | 34.07 | 459 / 459 |
brain | 100% | 1163.10 | 2640 / 2642 | 100% | 43.25 | 705 / 705 |
thymus | 100% | 1183.45 | 653 / 653 | 100% | 26.42 | 604 / 605 |
bladder | 100% | 1729.67 | 21 / 21 | 100% | 31.58 | 503 / 504 |
intestine | 100% | 1636.42 | 966 / 966 | 100% | 41.65 | 525 / 527 |
prostate | 100% | 1242.25 | 245 / 245 | 100% | 19.41 | 500 / 502 |
ovary | 100% | 1247.82 | 180 / 180 | 100% | 14.57 | 428 / 430 |
lung | 99% | 1098.75 | 575 / 578 | 100% | 24.60 | 1155 / 1155 |
skin | 100% | 2415.20 | 1808 / 1809 | 99% | 42.29 | 467 / 472 |
adrenal gland | 100% | 1714.21 | 258 / 258 | 99% | 21.47 | 227 / 230 |
pancreas | 99% | 651.25 | 325 / 328 | 99% | 24.17 | 177 / 178 |
kidney | 100% | 1110.92 | 89 / 89 | 98% | 17.58 | 884 / 901 |
liver | 98% | 577.06 | 222 / 226 | 97% | 12.61 | 394 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.98 | 29 / 29 |
spleen | 100% | 1107.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.81 | 1 / 1 |
adipose | 100% | 1192.29 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1339.85 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1177.13 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1272.38 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 27.93 | 78 / 80 |
peripheral blood | 77% | 739.45 | 712 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005674 | Cellular component | transcription factor TFIIF complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GTF2F2 |
Protein name | General transcription factor IIF subunit 2 (Transcription initiation factor IIF subunit beta) General transcription factor IIF subunit 2 (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30) |
Synonyms | RAP30 |
Description | FUNCTION: TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. . |
Accessions | ENST00000340473.8 P13984 ENST00000706694.1 A0A9L9PX76 |